MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Model Number VAMF2424C100TE |
Device Problem
Leak/Splash (1354)
|
Patient Problem
Chest Pain (1776)
|
Event Date 04/23/2024 |
Event Type
Injury
|
Event Description
|
A valiant captivia stent graft ((b)(6)) was implanted during the emergent endovascular treatment of a 60mm thoracic aortic pseudoaneurysm in the descending aorta.The proximal diameter at the lsa was 21mm and 40mm in length.Thrombus/calcification was present at the proximal and distal implantation site.The patient had presented with chest pain one day before the index procedure.It was reported one day post the index procedure, the patient reported chest pain.Ct identified a type iiib endoleak suspected to be caused by a defect in the graft fabric.Intervention was performed where an additional valiant captivia stent graft ((b)(6)) was implanted within the existing valiant captivia stent graft, effectively resolving the type iiib endoleak.Per the physician the cause of the type iiib endoleak was due to a defect in the stent graft fabric.No additional clinical sequelae were provided, and the patient is fine.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|